Form 4 for MEDP Medpace Holdings, Inc.
Accepted 2021-08-31 00:00:00 ET · period of report 2021-08-27 · accession 0001567619-21-016509 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2021-08-31 | 2021-08-27+ | MEDP | Troendle August J. | CEO, Dir, 10% | S - Sale | $182.50 | -24.1K | 6.02M | -0.4% | -$4.39M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-27 | S | D | 11,840 | $181.83 | 6,027,255 | I By Medpace Investors, LLC | — | — | (F1) The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Medpace Investors, LLC ("MPI") on March 12, 2021. (F2) The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $180.4175 to $183.86. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. (F3) The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. |
| 2 | Common | Common Stock | 2021-08-30 | S | D | 12,236 | $183.14 | 6,015,019 | I By Medpace Investors, LLC | — | — | (F1) The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Medpace Investors, LLC ("MPI") on March 12, 2021. (F4) The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $180.57 to $184.80. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. (F3) The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. |